RESUMO
Asymmetry in childcare responsibilities is one of the main reasons behind gender gaps in the labor market. In that context, the ability to work from home may alleviate the hindrances of women with children to participate in the labor market. We study these issues in Latin America, a region with wide gender gaps, in the framework of a major shock that severely affected employment: the COVID-19 pandemic. In particular, we estimate models of job loss exploiting microdata from the World Bank's High-Frequency Phone Surveys conducted immediately after the onset of the pandemic. We find that the mitigating effect of working from home on the severity of job losses was especially relevant for women with children. The results are consistent with a plausible mechanism: due to the traditional distribution of childcare responsibilities within the household, women with children were more likely to stay home during school closures, and therefore the ability to work from home was crucial for them to keep their jobs.
RESUMO
We use longitudinal data from the Mexican Health and Aging Study to analyze the effect of having a parent in need of long-term care on labor supply of men and women aged 50-64 in Mexico. After accounting for both individual and time fixed effects, we find that parents' need of long-term care is associated with both a significant drop in the likelihood of working (by 2.42 percentage points), and a reduction in the number of hours worked (by 7.3%) among women who remain employed. In contrast, we find no effect on the labor supply of men. In a context of rapid population aging, the increase in the need of long-term care risks to hinder the efforts to reduce gender imbalances in the labor market.
RESUMO
The ability to work from home can be critical during pandemics. We calculate an index that measures the possibility of working from home based on the characteristics of the pre-Covid-19 pandemic distribution of occupations and on internet access at home, using microdata for Mexico. Focusing on households with two partners employed in nonessential occupations, we show that there is high within-household correlation in the possibility of working remotely, which is likely to be positively associated with job stability during the pandemic. Poor families, with low access to formal credit and who rely heavily on informal mechanisms for consumption smoothing have lower chances of working remotely than richer families with higher access to formal credit. High within-household correlation in the work-from-home index restricts the likelihood of intra-household risk-sharing and consumption smoothing, and is likely to contribute to an increase in inequality.
RESUMO
Objectives: There is a lack of data in Panama on the potential differences in total healthcare professional (HCP) time between routine administrations of short-acting erythropoietin simulating agents (ESAs) (i.e. epoetin alfa) and continuous erythropoietin receptor activator (CERA) (i.e. methoxy polyethylene glycol-epoetin beta). This study aimed to quantify the HCP time associated with a single administration of epoetin alfa and CERA for the treatment of anemic patients with chronic kidney disease (CKD) on hemodialysis. Methods: This was a multi-center, cross-sectional study, using a time-and-motion methodology. Costs related to HCP time and consumables usage associated with administration of epoetin alfa and CERA were estimated. Results: Based on 60 administrations of either CERA or epoetin alfa, the estimated savings in mean total active HCP time were 2.34 (95% confidence interval = 1.87-2.81) min (-30%) per administration. When extrapolating to a full year's treatment with intravenous ESA, it would require a total of 20.3 (95% CI = 19.90-20.71) h of HCP time for epoetin alfa vs 1.1 (95% CI = 1.01-1.19) h for CERA per patient per year. Estimated savings in active HCP time per patient per year were 19.20 (95% CI = 19.20-19.21) h (-95%). This, in turn, translates into staff cost efficiency that favors Mircera with an estimated annual saving of $78.24 (95% CI = 78.24-78.28) (-95%) per patient. Conclusions: Data from a real-world setting showed that the adoption of CERA could potentially lead to a reduction in active HCP time. Highlights Few comparative data have explored the costs and potential savings of using long-acting erythropoietin-stimulating agents (ESA) instead of short-acting ESAs to treat anemia in CKD patients on hemodialysis. This time-and-motion study shows that use of CERA reduces total healthcare professional time and could represent a save for an institution in a real-world setting in Panama.